GILD Gilead Sciences Inc

Gilead Sciences Inc is a biopharmaceutical company that discovers, develops and commercializes new medicines in areas of unmet medical need. Its products target a number of areas, such as HIV, liver diseases, cardiovascular and other diseases.

$67.45  +0.23 (0.34%)
As of 05/12/2021 16:00:01 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Large cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—General
Index country:  USA
Country of incorporation:  USA
IPO date:  02/20/2001
Outstanding shares:  1,254,178,166
Average volume:  7,385,215
Market cap:   $84,631,942,642
Current dividend yield:  4.01%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    375558103
ISIN:        US3755581036
Sedol:      2369174
Valuation   (See tab for details)
PE ratio:   280.09
PB ratio:   4.45
PS ratio:   3.31
Return on equity:   1.59%
Net income %:   1.18%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy